Back to mobile site

Adaptive Biotechnologies (ADPT) Misses Q3 EPS by 1c

November 9, 2023 4:38 PM EST

Adaptive Biotechnologies (NASDAQ: ADPT) reported Q3 EPS of ($0.35), $0.01 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $37.92 million versus the consensus estimate of $42.96 million.

For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings